SOURCE: Daxor Corp.

September 06, 2007 08:30 ET

Daxor Announces NorthCrest Medical Center of Springfield, TN Acquires Blood Volume Analyzer BVA-100

NEW YORK, NY--(Marketwire - September 6, 2007) - Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement for a Blood Volume Analyzer BVA-100 from NorthCrest Medical Center of Springfield, Tennessee.

NorthCrest Medical Center is a fully accredited, 109-bed facility servicing Robertson and surrounding Tennessee counties as well as southern Kentucky. Supported by state-of-the-art equipment, including an in-house cardiovascular lab, a full range of outpatient services and 24-hour emergency services, NorthCrest Medical Center's mission is to be the best 150-bed-or-less hospital in the country. NorthCrest Medical Center features more than 150 active and consulting physicians on the medical center staff providing a variety of services, which include cardiology, diagnostic and interventional radiology, emergency medicine, family practice, internal medicine, nephrology, neurology, obstetrics/gynecology ophthalmology, orthopedics, otolaryngology (ear, nose and throat), pediatrics, plastic and reconstructive surgery, pulmonology, general and vascular surgery, and urology.

NorthCrest Medical Center's interest in utilizing Daxor's Blood Volume Analyzer BVA-100 is to provide precise diagnostic information to physicians treating medical conditions in which intravascular blood volume abnormalities are frequently present but difficult to diagnose without the benefit of the BVA-100. Specifically, the BVA-100 will be used to diagnose intravascular blood volume derangements in heart failure, critical care and hematological conditions.

Other nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a clinical trial agreement basis are The Mayo Clinic, The Cleveland Clinic, and New York University Medical Center. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.

Contact Information

  • Contact Information:
    Stephen Feldschuh
    Chief Operating Officer
    212-330-8515
    Email Contact

    or

    Diane Meegan
    Investor Relations
    212-330-8512
    Email Contact